Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: RXGOLF who wrote (29395)	11/15/1999 8:42:00 PM
From: bluejeans	Respond to of 32384

Here is a good site for after hour Nasdaq trades: nasdaq.com And amazingly it is already loaded for LGND<G>

To: RXGOLF who wrote (29395)	11/15/1999 9:00:00 PM
From: WTDEC	Read Replies (2) \| Respond to of 32384

RX, from CBS News: "Shares of Ligand Pharmaceuticals (LGND: news, msgs) also rose in after-hours trading after posting third-quarter revenue of $9.8 million, a 151 percent increase over the $3.9 million posted last year. Ligand's net loss of 39 cents a share for quarter was greater than the 31 cents a share loss expected by analysts but an improvement over the $1.15 per share loss posted the same period last year. Ligand also noted it is scheduled to meet with the FDA 's Oncologic Drugs Advisory Committee on December 13 to review the submission of Targretin capsules. The FDA is expected to issue an action letter on the filing soon thereafter. Ligand gained 1/2 in Instinet after-hours trading to 10 3/4. <SNIP> cbs.marketwatch.com